We target businesses across the drug development value chain—including CDMO, API, and preclinical services—where increasing outsourcing, complexity, and regulatory burden create long-term growth dynamics.

We look for specialist care providers, diagnostics, and healthcare logistics platforms with scalable models and strong compliance capabilities.

We favour technically differentiated businesses with strong IP, recurring demand, and supply chain advantages.

We focus on producers with high-margin formulations, regulatory complexity, or defensible niche applications.

Our interest lies in compliance-driven, asset-light services with recurring revenue and consolidation potential.

We seek operators in temperature-controlled, security-sensitive, or regulated supply chains where reliability and reputation are core differentiators.